Maria-Luisa Maccecchini

President & CEO

Maria-Luisa Maccecchini (President & CEO) filed 1 Form 4 report in the trailing twelve months (1 purchase, 0 sales, 1 filed past the two-business-day deadline), most often in Annovis Bio, Inc. (ANVS). Across 1 priced purchase filing, the average 21-session return was +127.4% from execution and +74.7% from disclosure (delay-adjusted; derived). The largest single filing was $200K of ANVS (97,561 sh × $2.05, as filed), executed Oct 28 2025.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

+127.4%

avg across 1 priced filings

Delay-adjustediThe same average, entered at disclosure dates

+74.7%

same 1 filings, from disclosure

Filings, ttm

1 buys · 0 sells · 1 late

Median delay

15d

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$200K

shares × price, as filed

Last traded

Oct 28 2025

Filed Nov 12 2025

Open performance→

Volume by month

Buys $200K Sells $0

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 1 filing

Sector per market data · by filing · past 12 months

Most traded names

ANVS

Annovis Bio, Inc. ANVS · 1 buy · 0 sells 1 filing

Recent filings

ANVSPURCHASE Annovis Bio, Inc. View filing → $200K
97,561 sh × $2.05
Exec Oct 28 2025
Filed Nov 12 2025 · 9:19 AM ET †